Breast & Cervical Cancer QI Program

The Ohio Academy of Family Physicians has created a data collection module to assist members and their practice teams in improving the care women receive related to prevention and early detection of breast & cervical cancer. This module is free to OAFP members (American Board of Family Medicine (ABFM) fees still apply). By utilizing the module, you will improve practice team engagement, benchmark patient data, select a pathway for care delivery intervention, and re-measure outcome data after a three month change period. The module will systematically guide participants through a Plan, Do, Study, Act cycle to improve the care provided to female patients.

The module is accredited by the American Board of Family Medicine (ABFM) as an alternative Family Medicine Certification Performance Improvement (formerly known as MC-FP Part IV) activity and is accredited by the American Academy of Family Physicians for Performance Improvement in Practice credits.

Learn more about completing the breast & cervical cancer module and view the tutorial video below.


Learning Objectives

Participants in this module will:
  1. Understand the importance of practice team engagement on improving cancer prevention and screening rates among female patients
  2. Determine the gaps in the breast and cervical screening that is currently being provided to female patients
  3. Put interventions into practice and work for improvement in breast and cervical screening
  4. Identify strategies to discuss appropriate cancer screenings with their female patients
  5. Demonstrate improvements in patient care as a result of systems changes identified through quality improvement initiatives.

Resources, References & Tools for Completing the Module

Within the module, once you complete your practice assessment and chart review, you will focus on a practice improvement strategy. Below are pathways within the module that you can choose from to improve the care of female patients. Within each pathway are several interventions. To complete this module, you will need to select one intervention to implement into practice.

Cancer Prevention: Women age 21 – 26 years old
Cancer Screening: Women age 50 – 65 years old

Accreditation Statement

This activity has been approved by the ABFM for Performance Improvement credit toward Family Medicine Certification Requirements (formerly known as MC-FP Part IV). Term of approval is for two years beginning June 1, 2016, with the option for yearly renewal thereafter. Please note that once an activity is started, it must be completed within one calendar year. If the activity is not completed in that time, the activity must be restarted. In addition, for the alternate Performance Improvement activity to apply toward the Family Medicine Certification requirement, it must be completed in the stage the Diplomate wishes to receive the credit. To fully implement your practice improvement plan and analyze your results, it will take you a minimum of three months to complete the process. Please plan accordingly.

Although there is no cost to utilize this module, ABFM Diplomates who complete alternate Performance Improvement activities must submit the required Family Medicine Certification fees to the ABFM in order to receive credit for the alternate activity.

This Performance Improvement in Practice activity, Breast & Cervical Cancer QI Program, has been reviewed and is acceptable for up to 20.00 Prescribed credit(s) by the AAFP.  Term of approval began June 1, 2016. Term of approval is for two years from this date.

Once the module has been completed, the OAFP will report final credit of the participating physician to the AAFP and the ABFM so long as the physician’s ABFM and AAFP member numbers were accurately submitted in the profile record. Participants who successfully complete the activity, post test, and evaluation will have a statement of credit made available immediately.

Statement of Need

According to the American Cancer Society, it is estimated that in 2015, approximately 12,900 new cases of invasive cervical cancer will be diagnosed and 4,100 women will die of the disease. The National Cancer Institute reports that in this same year, it is estimated that there will be 231,840 new cases of breast cancer and an estimated 40,290 deaths from the disease.

Fortunately, the Affordable Care Act (ACA) will increase access to screening for cervical and breast cancers, especially for underserved and low income women, according to the CDC. As the United States struggles to bring healthcare costs under control, it is important for physicians to know and incorporate into practice, the latest guidelines regarding screening for cervical and breast cancers.


  • Ryan Kauffman, MD, (Project Champion)
  • Theresa Barrett, PhD, CMP, CAE
  • Kenneth Bertka, MD
  • Heidi Gullett, MD, MPH
  • Douglas Harley, DO
  • Gary LeRoy, MD


  • Alexandria Howard, MD
  • Erin Jech
  • Mary Krebs, MD
  • Kate Mahler, CAE
  • Terry Wagner, DO
  • Cynthia Weinstein, MD
  • Steve Zitelli, MD

Faculty Disclosure

The OAFP adheres to the conflict-of-interest policy of the AAFP as well as to the guidelines of the Accreditation Council for Continuing Medical Education and the American Medical Association. Current guidelines state that participants in continuing medical education activities should be made aware of any affiliation or financial interest that may affect an author’s article.

The members of this expert panel have completed conflict-of-interest statements. Disclosures do not suggest bias but provide readers with information relevant to the evaluation of the contents of these recommendations.

Commercial Support

This module was supported by Grant Number 5U58DP003936 funded by the CDC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Department of Health and Human Services.

If you have questions regarding this program, please contact Director of Performance Improvement Erin Jech or call 800.742.7327.